Effects of chronic obstructive pulmonary disease on coronary atherosclerosis

Heart and Vessels

Volumn 24, Issue 3, 2009, Pages 164-168

  Topsakal, Ramazan ^a   Kalay, Nihat ^b   Ozdogru, Ibrahim ^a   Cetinkaya, Yakup ^a   Oymak, Sema ^a   Kaya, Mehmet Gungor ^a   Dogan, Ali ^a   Inanc, Mehmet Tugrul ^a   Ergin, Ali ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b Sorgun Devlet Hastanesi   (Turkey)

Author keywords

Chronic obstructive pulmonary disease; Coronary artery disease; Extents core; Gensinis core

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBON DIOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OXYGEN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD GAS ANALYSIS; CARBON DIOXIDE TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; OXYGEN TENSION; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM;

AGED; BLOOD GAS ANALYSIS; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 66149116830     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1103-4     Document Type: Article

References (32)

1. Schols AM (2002) Pulmonary cachexia. Int J Cardiol 85:101-110
2. Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X (2003) Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 21:347-360
3. Stewart AG, Waterhouse JC, Howard P (1991) Cardiovascular autonomic nerve function in patients with chronic obstructive pulmonary disease. Eur Respir J 4:1207-1214
4. Vizza CD, Lynch JP, Ochoa LL, Richardson G, Trulock EP (1998) Right and Left Ventricular Dysfunction in Patients with Severe Pulmonary Disease. CHEST 113:576-583
5. Basili S, Ferroni P, Vieri M, Cardelli P, Ceci F, Paradiso M, Labbadia G, Gazzaniga PP, Cordova C, Alessandri C (1999) Lipoprotein(a) serum levels in patients affected by chronic obstructive pulmonary disease. Atherosclerosis 147:249-252
6. Hole DJ, Watt GCM, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM (1996) Impaired lung function and mortality risk in men and women findings from the Renfrew and Paisley prospective population study. Br Med J 313:711-715
7. Repine JE, Bast A, Lankhorst I (1997) Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 156:341-357
8. MacNee W, Rahman I (2001) Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease? Trends Mol Med 7:55-62
9. Sin DD, Man SFP (2003) Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107:1514-1519
10. American Thoracic Society (1987) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136:225-244
11. Enbergs A, Burger R, Reinecke H, Borggrefe M, Breithardt G, Kerber S (2000) Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease: Angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy. Eur Heart J 21:45-52
12. Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51: 606-607
13. Sullivan DR, Marwick TH, Freedman SB (1990) A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 119:1262-1267
14. Zaacks SM, Allen JE, Calvin JE, Schaer GL, Palvas BW, Parrillo JE, Klein LW (1998) Value of The American College of Cardiology/American Heart Association Stenosis Morphology Classification for Coronary Interventions in the Late 1990s. Am J Cardiol 82:43-49
15. Mosseri M, Yarom R, Gotsman MS, Hasin Y (1986) Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 74:964-972
16. Markis JE, Joffe CD, Cohn PF, Feen DJ, Herman MV, Gorlin R (1976) Clinical significance of coronary arterial ectasia. Am J Cardiol 37:217-222
17. Rounds S, Piggott D, Dawicki DD, Farber HW (1997) Effect of hypercarbia on surface proteins of cultured bovine endothelial cells. AJP-Lung 273:1141-1146
18. DG Kiely, RI Cargill and BJ (1996) Lipworth Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans. Chest 109:1215-1221
19. Leach RM, Forsling ML (2004) The effect of changes in arterial PCO2 on neuroendocrine function in man. Exp Physiol 89: 287-292
20. Chabot F, Mertes PM, Delorme N, Schrijen FV, Saunier CG, Polu JM (1995) Effect of acute hypercapnia on alpha atrial natriuretic peptide, renin, angiotensin II, aldosterone, and vasopressin plasma levels in patients with COPD. Chest 107:780-786
21. Zouridakis E, Avanzas P, Arroyo-Espliguero R, Fredericks S, Kaski JC (2004). Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 110:1747-1753
22. Kobayashi S, Inoue N, Ohashi Y, Terashima M, Matsui K, Mori T, Fujita H, Awano K, Kobayashi K, Azumi H, Ejiri J, Hirata K, Kawashima S, Hayashi Y, Yokozaki H, Itoh H, Yokoyama M (2003) Interaction of oxidative stress and inflammatory response in coronary plaque instability important role of C-reactive protein. Arterioscler Thromb Vasc Biol 23:1398-1404
23. Avanzas P, Arroyo-Espliguero R, Garcia-Moll X, Kaski JC (2005) Inflammatory biomarkers of coronary atheromatous plaque vulnerability. Panminerva Med 47:81-91
24. Hunninghake DB (2005) Cardiovascular disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2:44-49
25. Hageman GJ, Larik I, Pennings HJ, Haenen GR, Wouters EF, Bast A (2003) Systemic poly(ADP-RIBOSE) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients. Free Radic Biol Med 35:140-148
26. Ashitani J, Mukae H, Arimura Y, Matsukura S (2002) Elevated plasma procoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease. Intern Med 41:181-185
27. Schroeder EB, Welch VL, Couper D, Nieto FJ, Liao D, Rosamond WD, Heiss G (2003) Lung function and incident coronary heart disease: The Atherosclerosis Risk in Communities Study. Am J Epidemiol 158:1171-1181
28. Mancini GB, Etminan M, Zhang B, Levesque LE, FitzGerald JM, Brophy JM (2006) Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 47:2554-2560
29. Murasaki S, Murasaki K, Tanoue K, Kawana M, Hagiwara N, Kasanuki H. (2007) Circulating platelet and neutrophil activation correlates with the clinical course of unstable angina. Heart Vessels 22:376-382
30. Yamagata T, Sugiura H, Yokoyama T, Yanagisawa S, Ichikawa T, Ueshima K, Akamatsu K, Hirano T, Nakanishi M, Yamagata Y, Matsunaga K, Minakata Y, Ichinose M. (2007) Overexpression of CD-11b and CXCR1 on circulating neutrophils: Its possible role in COPD. Chest 132:890-899
31. Otsui K, Inoue N, Kobayashi S, Shiraki R, Honjo T, Takahashi M, Hirata K, Kawashima S, Yokoyama M. (2007) Enhanced expression of TLR4 in smooth muscle cells in human atherosclerotic coronary arteries. Heart Vessels 22:416-422
32. MacRedmond RE, Greene CM, Dorscheid DR, McElvaney NG, O'Neill SJ. (2007) Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Respir Res 8:84